La Roche-Posay Effaclar AI Breakout Corrector is a targeted treatment for individual blemishes. Specifically formulated for oily, blemish-prone skin. An easy-to-apply, quickly absorbed, targeted SOS treatment to help reduce the appearance of localised imperfections and blemishes and prevent residual marks.
- Targets individual blemishes
- Designed for oily skin and sensitive skin prone to breakouts
- Helps prevent residual marks from acne
- Fights against the imperfection cause
- Activates the skin’s regenerations process
- Suitable for all skin types including the most sensitive
- Hypoallergenic and dermatologically tested
ACTIVE INGREDIENTS
Enriched with Niacinamide, Piroctone Olamine and LHA
Ingredients
609364 46
Aqua / Water
Cyclohexasiloxane
Isononyl Isononanoate
Propylene Glycol
Isohexadecane
Niacinamide
PEG-100 Stearate
Glyceryl Stearate
Cetyl Alcohol
Magnesium Aluminum Silicate
Carbomer
Sodium Hydroxide
Capryloyl Glycine
Capryloyl Salicylic Acid
Citric Acid
Xanthan Gum
Acrylates Copolymer
Salicylic Acid
Iodopropynyl Butylcarbamate
Chlorhexidine Digluconate
Piroctone Olamine
Parfum / Fragrance
(Code F.I.L. B36956/3)
Please check back of pack for up to date ingredients
How To Use
1 CLEANSE
Work a small amount of cleanser into a lather with water and massage onto skin using gentle circular scrubbing movements – no need to scrub. Avoid eye area. Rinse thoroughly.
Recommended: LA ROCHE-POSAY EFFACLAR PURIFYING GEL
2 MOISTURISE
Apply a thin layer of cream over entire face before applying make up. Avoid eye contour.
Recommended: LA ROCHE-POSAY EFFACLAR DUO [+]
3 TARGET BLEMISHES
Apply breakout corrector to individual blemishes.
Recommended: LA ROCHE-POSAY EFFACLAR A.I.
Results
Targeted blemish control that helps to reduce the appearance of breakouts and prevent residual marks. Skin looks and feels clearer and smoother. Imperfections are visibly reduced as are residual marks.
Delivery Options
Standard Delivery
€5 or free when you spend €40 of more
For more information see our delivery page
Reviews
There are no reviews yet.